Lipid control and stroke risk in atrial fibrillation patients treated with direct oral anticoagulants and statins
European Stroke Journal · 2025
DOI: 10.1177/23969873241272530 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Stroke Journal, 2025. Verfasst von Bonaventure Ip und 12 weiteren Autor:innen. Beteiligte Einrichtung: Medical Data Analytics Centre, The Chinese University of Hong Kong, Hong Kong SAR, China. Hauptthemen laut MEDLINE: Atrial Fibrillation, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Ischemic Stroke, Anticoagulants. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Themen: Schlaganfall
Abstract (Originalsprache)
Introduction
The risk of ischemic stroke and intracerebral hemorrhage (ICH) with intensive lipid control by statins among patients with atrial fibrillation (AF) who require direct oral anticoagulants (DOAC) is unclear. We aimed to determine the risks of ischemic stroke and ICH in AF patients treated with DOAC and statins. Patients and methods: In a population-based retrospective cohort study, we identified AF patients concurrently on DOAC and statins from 2015 to 2021 in Hong Kong. Primary outcome was ischemic stroke. Secondary outcomes were ICH and death. We correlated study outcomes with low-density lipoprotein cholesterol (LDL-C) and high-density lipoprotein cholesterol (HDL-C) as time-varying, continuous variables with restricted cubic spline. In secondary analyses, the risks of study outcomes with statin intensity (low, moderate, high) were determined by multivariable time-dependent marginal structural Cox models.
Results
We identified 32,752 AF patients co-prescribed with DOAC and statins. Lower LDL-C (p < 0.001) and higher HDL-C (p < 0.001) levels were associated with lower risk of ischemic stroke but not significantly associated with ICH. LDL-C of <1.8 mmol/L (70 mg/dL) was not associated with mortality (19.6% vs 18.4%, difference 1.2% [95% CI −0.35 to 2.13]). High-intensity statin was associated with a lower risk of ischemic stroke compared with low-intensity statin (weighted Cox-specific hazard ratio [95% CI]: 0.82 [0.67–0.99], p = 0.040) independent of LDL-C levels. Similar associations were found in 11,444 AF patients with a history of ischemic stroke. Discussion and conclusion: Intensive lipid control by high-intensity statins was associated with a lower risk of ischemic stroke in AF patients who required DOACs and did not appear to increase the risk of ICH.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Medical Data Analytics Centre, The Chinese University of Hong Kong, Hong Kong SAR, China.
- Department of Medicine and Therapeutics, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong SAR, China.
- Li Ka Shing Institute of Health Sciences, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong SAR, China.
- Department of Neurology, Inselspital University Hospital Bern and University of Bern, Bern, Switzerland.
- Department of Neurology, McMaster University, Canada.
ORCID-Profile: Bonaventure Ip, David Seiffge, Ashkan Shoamanesh
Zitieren
APA
Ip, B., Yip, T., Hung, T., Yam, T. F., Yeung, C., Ko, H., Wong, G., Leng, X., Mok, V., Soo, Y., Seiffge, D., Shoamanesh, A., & Leung, T. (2025). Lipid control and stroke risk in atrial fibrillation patients treated with direct oral anticoagulants and statins. European Stroke Journal. https://doi.org/10.1177/23969873241272530
Vancouver
Ip B, Yip T, Hung T, Yam TF, Yeung C, Ko H, et al. Lipid control and stroke risk in atrial fibrillation patients treated with direct oral anticoagulants and statins. European Stroke Journal. 2025. doi:10.1177/23969873241272530
BibTeX
@article{Ip2025,
author = {Ip, Bonaventure and Yip, Terry and Hung, Trista and Yam, Tsz-Fai and Yeung, Carly and Ko, Ho and Wong, Grace and Leng, Xinyi and Mok, Vincent and Soo, Yannie and Seiffge, David and Shoamanesh, Ashkan and Leung, Thomas},
title = {Lipid control and stroke risk in atrial fibrillation patients treated with direct oral anticoagulants and statins},
journal = {European Stroke Journal},
year = {2025},
doi = {10.1177/23969873241272530}
}
EUVIMED